As more and more people die from opioid overdoses, it’s time for pharma to own up to its collective responsibility and come up with a solution.
Big pharma should extend its vision beyond the blockbusters to make room for orphan drugs.
In short, CEOs can’t be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.
Back Talk.pdf Joel Peterson, a favorite Wall Street Journal columnist, recently examined the benefits a CEO might offer as president of the US. I suspect his thesis may have been facetious, but he raised a few intriguing points. The energy and drive of a successful business executive would seem ideal for the Oval Office. Who…